An open label phase II study of Liprostin for the treatment of Diabetic Neuropathy in patients affected by non-healing ulcers of the foot or ankle
Latest Information Update: 05 Aug 2016
At a glance
- Drugs Alprostadil (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- 05 Aug 2016 New trial record